The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final survival analysis of the phase III OVHIPEC-1 trial of hyperthermic intraperitoneal chemotherapy in ovarian cancer after ten year follow-up.
 
Lot Aronson
No Relationships to Disclose
 
Marta I. Lopez-Yurda
No Relationships to Disclose
 
Simone N Koole
No Relationships to Disclose
 
Jules H Schagen van Leeuwen
No Relationships to Disclose
 
Henk Schreuder
No Relationships to Disclose
 
Ralph Hermans
No Relationships to Disclose
 
Ignace H.J.T. de Hingh
Research Funding - QP&S/RanD (Inst); Roche (Inst)
 
Mignon D.J.M. Van Gent
No Relationships to Disclose
 
Henriëtte J.G. Arts
No Relationships to Disclose
 
Maaike van Ham
No Relationships to Disclose
 
Peter Van Dam
No Relationships to Disclose
 
Peter Vuylsteke
Honoraria - MSD Oncology; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Roche
 
Arend Aalbers
No Relationships to Disclose
 
Victor Verwaal
No Relationships to Disclose
 
Koen Van de Vijver
Consulting or Advisory Role - AstraZeneca (Inst); Exact Sciences (Inst)
Speakers' Bureau - GlaxoSmithKline (Inst)
 
Neil K Aaronson
No Relationships to Disclose
 
Gabe S. Sonke
Consulting or Advisory Role - Biovica (Inst); Novartis (Inst); Seagen (Inst)
Research Funding - Agendia (Inst); AstraZeneca/Merck (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Willemien Van Driel
No Relationships to Disclose